The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Antineoplastic Drugs in Elderly Patients
Official Title: Population Pharmacokinetics, Effectiveness and Safety of Antineoplastic Drugs in Elderly Patients
Study ID: NCT05467189
Brief Summary: The purpose is to study the population pharmacokinetics, effectiveness and safety of antineoplastic drugs (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib, Imatinib, Lapatinib, etc) in elderly patients and recommend optimized dosage regimens.
Detailed Description:
Minimum Age: 65 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China
Name: Zhao Wei, Ph.D
Affiliation: Qianfoshan Hospital
Role: STUDY_CHAIR